I agree that this site is using cookies. You can find further informations here.
X
Fashoyin-Aje, Lola A.
50  results:
Search for persons X
?
1

Transcriptomic analysis of pancreatic adenocarcinoma specim..:

Biel, Thomas G. ; Petrovskaya, Svetlana ; Mascia, Francesca...
PLOS ONE.  18 (2023)  2 - p. e0281182 , 2023
Link: https://doi.org/10.1371/..
 
?
2

Researcher Experience and Comfort With Telemedicine and Rem..:

Lichtenstein, Morgan R L ; Levit, Laura A ; Schenkel, Caroline...
The Oncologist.  29 (2023)  4 - p. 356-363 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Association between antibiotics and adverse oncological out..:

Pinato, David J. ; Li, Xiaoxue ; Mishra-Kalyani, Pallavi...
JHEP Reports.  5 (2023)  6 - p. 100747 , 2023
Link: https://doi.org/10.1016/..
 
?
4

FDA Analysis of Ineligibility for Acute Myeloid Leukemia Cl..:

Pulte, Dianne ; Fernandes, Laura ; Wei, Guo...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  6 - p. 463-470.e1 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Assessing the Needs of Those Who Serve the Underserved: A Q..:

Patel, Manali I. ; Hinyard, Leslie ; Hlubocky, Fay J....
Cancers.  15 (2023)  13 - p. 3311 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Development of Tissue-Agnostic Treatments for Patients with..:

Lemery, Steven ; Fashoyin-Aje, Lola ; Marcus, Leigh...
Annual Review of Cancer Biology.  6 (2022)  1 - p. 147-165 , 2022
Link: https://doi.org/10.1146/..
 
?
7

Evaluation of Treatment Effect in Underrepresented Populati..:

Sridhara, Rajeshwari ; Marchenko, Olga ; Jiang, Qi...
Statistics in Biopharmaceutical Research.  15 (2022)  2 - p. 450-456 , 2022
Link: https://doi.org/10.1080/..
 
?
8

Reimagining patient-centric cancer clinical trials: a multi..:

Li, Bob T. ; Daly, Bobby ; Gospodarowicz, Mary...
Nature Medicine.  28 (2022)  4 - p. 620-626 , 2022
Link: https://doi.org/10.1038/..
 
?
9

Analysis of racial and ethnic disparities in multiple myelo..:

Kanapuru, Bindu ; Fernandes, Laura L. ; Fashoyin-Aje, Lola A....
Blood Advances.  6 (2022)  6 - p. 1684-1691 , 2022
Link: https://doi.org/10.1182/..
 
?
10

To Adjudicate or Not Adjudicate:

Hicks, Karen A. ; Fashoyin-Aje, Lola A. ; Amiri-Kordestani, Laleh
JACC: CardioOncology.  4 (2022)  5 - p. 657-659 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Exploring racial disparities in treatment patterns and outc..:

Maignan, Kathleen ; Fashoyin-Aje, Lola A. ; Torres, Aracelis Z....
Blood Cancer Journal.  12 (2022)  4 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
12

Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: Fro..:

Chang, Elaine ; Pelosof, Lorraine ; Lemery, Steven...
The Oncologist.  26 (2021)  10 - p. e1786-e1799 , 2021
Link: https://doi.org/10.1002/..
 
?
13

Making cancer research more inclusive:

Carpten, John D. ; Fashoyin-Aje, Lola ; Garraway, Levi A..
Nature Reviews Cancer.  21 (2021)  10 - p. 613-618 , 2021
Link: https://doi.org/10.1038/..
 
?
14

FDA Approval Summary: Nivolumab Plus Ipilimumab for the Tre..:

Saung, May Tun ; Pelosof, Lorraine ; Casak, Sandra...
The Oncologist.  26 (2021)  9 - p. 797-806 , 2021
Link: https://doi.org/10.1002/..
 
?
15

Benefit–Risk Summary of Nivolumab for the Treatment of Pati..:

Pelosof, Lorraine ; Saung, May Tun ; Donoghue, Martha...
The Oncologist.  26 (2021)  4 - p. 318-324 , 2021
Link: https://doi.org/10.1002/..
 
1-15